Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2

Author(s): Judkowski V, Pinilla C, Schroder K, Tucker L, Sarvetnick N, et al.

Abstract

Nonobese diabetic (NOD) mice spontaneously develop insulitis and destruction of pancreatic islet beta cells similar to type 1 diabetes mellitis in humans. Insulitis also occurs in the BDC2.5 TCR transgenic line of NOD mice that express the rearranged TCR alpha- and beta-chain genes of a diabetogenic NOD CD4 T cell clone. When activated with syngeneic islet cells in culture, BDC2.5 T cells adoptively transfer disease to NOD recipients, but the identity of the islet cell Ag responsible for pathogenicity is not known. To characterize the autoantigen(s) involved, BDC2.5 T cells were used to screen a combinatorial peptide library arranged in a positional scanning format. We identified more than 100 decapeptides that stimulate these T cells at nanomolar concentrations; they are then capable of transferring disease to NOD-scid mice. Surprisingly, some of the peptides include sequences similar (8 of 10 residues) to those found within the 528-539 fragment of glutamic acid decarboxylase 65. Although this 12-mer glutamic acid decarboxylase 65 fragment is only slightly stimulatory for BDC2.5 T cells (EC(50) > 100 microM), a larger 16-mer fragment, 526-541, shows activity in the low micromolar range (EC(50) = 2.3 microM). Finally, T cells from prediabetic NOD mice respond spontaneously to these peptide analogs in culture; this finding validates them as being related to a critical autoantigen involved in the etiology of spontaneous diabetes and indicates that their further characterization is important for a better understanding of underlying disease mechanisms.

Similar Articles

Costimulation blockade: towards clinical application

Author(s): Weaver TA, Charafeddine AH, Kirk AD

The B7 family revisited

Author(s): Greenwald RJ, Freeman GJ, Sharpe AH

T-cell clonal anergy

Author(s): Schwartz RH, Mueller DL, Jenkins MK, Quill H

Induction of immunologic tolerance for transplantation

Author(s): Rossini AA, Greiner DL, Mordes JP

The role of peripheral T-cell deletion in transplantation tolerance

Author(s): Wells AD, Li XC, Strom TB, Turka LA

Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells

Author(s): Bour-Jordan H, Salomon BL, Thompson HL, Szot GL, Bernhard MR, et al.

The BB/Wor rat and the balance hypothesis of autoimmunity

Author(s): Mordes JP, Bortell R, Doukas J, Rigby M, Whalen B, et al.

The pathogenesis of autoimmune diabetes mellitus

Author(s): Rossini AA, Mordes JP, Greiner DL

Induction of immunological tolerance to islet allografts

Author(s): Rossini AA, Parker DC, Phillips NE, Durie FH, Noelle RJ, et al.

CD28/B7 regulation of autoimmune diabetes

Author(s): Herold KG, Lenschow DJ, Bluestone JA

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

Author(s): Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, et al.

Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates

Author(s): Adams AB, Shirasugi N, Durham MM, Strobert E, Anderson D, et al.

CD28/B7 regulation of anti-CD3-mediated immunosuppression in vivo

Author(s): Tang Q, Smith JA, Szot GL, Zhou P, Alegre ML, et al.

What's next in the pipeline

Author(s): Vincenti F, Kirk AD

Prolonged islet allograft survival in diabetic NOD mice by targeting CD45RB and CD154

Author(s): Molano RD, Pileggi A, Berney T, Poggioli R, Zahr E, et al.

Islet cell transplantation tolerance

Author(s): Rossini AA, Mordes JP, Greiner DL, Stoff JS

Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand

Author(s): Kawai T, Andrews D, Colvin RB, Sachs DH, Cosimi AB

Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy

Author(s): Wells AD, Walsh MC, Bluestone JA, Turka LA

Differentiation of regulatory Foxp3+ T cells in the thymic cortex

Author(s): Liston A, Nutsch KM, Farr AG, Lund JM, Rasmussen JP, et al.

CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes

Author(s): Lenschow DJ, Herold KC, Rhee L, Patel B, Koons A, et al.

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

Author(s): Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, et al.

Expansion of human regulatory T-cells from patients with type 1 diabetes

Author(s): Putnam AL, Brusko TM, Lee MR, Liu W, Szot GL, et al.

Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors

Author(s): Hsieh CS, Liang Y, Tyznik AJ, Self SG, Liggitt D, et al.

Insulin dependent diabetes mellitus hypothesis of autoimmunity

Author(s): Rossini AA, Handler ES, Greiner DL, Mordes JP